Skip to search formSkip to main contentSkip to account menu

Enalaprilat

Known as: Enalaprilat [Chemical/Ingredient], N-(1(S)-Carboxy-3-phenylpropyl)-L-alanyl-L-proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2) 
The active metabolite of the pro-drug enalapril, a dicarboxylate-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive… 
National Institutes of Health

Related topics

Related topics

25 relations
AngioedemaAngiotensin-Converting Enzyme Inhibitors [MoA]Bartter DiseaseCongestive heart failure

Broader (2)

Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents

Narrower (2)

MK-422Vasotec

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
Highly Cited
1999
Highly Cited
1999
Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P
1999
1999
Angiotensin‐converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers
1998
1998
Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill.
OBJECTIVE To assess the effects of the angiotensin-converting enzyme inhibitor enalaprilat on endothelial cells in septic… 
1997
1997
Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts.
Highly Cited
1995
Highly Cited
1995
Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors.
1995
1995
Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
BACKGROUND Vasodilator drugs have variable effects on veins and arteries. However, direct measurements of their effects on the… 
1993
1993
Angiotensin II and sympathetic activity in patients with congestive heart failure.
1989
1989
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Highly Cited
1985
Highly Cited
1985
Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)